Fleming William Kevin
- SEC CIK
- 0001699801
No open-market purchases or sales filed in the past year.
Current role at each company
- HUM Humana IncChief Corporate Aff. Officeras of Sep 30, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fleming William Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 (view filing) | Nov 3 | 4 days | Fleming William KevinSeg Pres, Pharmacy Sol & CCAO | SSaleHumana Common | −11.2K | $565.61 | −$6.31M | −81.4%2.54K after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Fleming William KevinSeg Pres, Pharmacy Sol & CCAO | SSaleHumana Common | −3.21K | $449.68 | −$1.44M | −78.4%884 after |